SCHEMBL351619

SCHEMBL351619

BrCCCCn1c2ccccc2c2ccccc21

nearest known ligand 0.58

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
FABP4 P15090 2/20 0.58
FABP5 Q01469 2/20 0.58
MAOA P21397 9/20 0.56
MAOB P27338 9/20 0.56
ACHE P22303 3/20 0.56
GRIN1 Q05586 7/20 0.53
GRIN2A Q12879 7/20 0.53
GRIN2B Q13224 7/20 0.53
HDAC1 Q13547 3/20 0.53
HDAC6 Q9UBN7 3/20 0.53
CYP1A2 P05177 1/20 0.52
CYP2C19 P33261 1/20 0.52
SLC6A2 P23975 1/20 0.49
SLC6A4 P31645 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30479089 1.00 FABP4 (0.58) FABP4FABP5MAOAMAOBACHE
SCHEMBL30274268 0.98 MAOA (0.59) FABP4FABP5MAOAMAOBACHE
SCHEMBL18010367 0.98 MAOA (0.59) FABP4FABP5MAOAMAOBACHE
SCHEMBL29433776 0.98 MAOA (0.59) FABP4FABP5MAOAMAOBACHE
SCHEMBL4203950 0.98 MAOA (0.59) FABP4FABP5MAOAMAOBACHE
SCHEMBL25354476 0.98 MAOA (0.59) FABP4FABP5MAOAMAOBACHE
SCHEMBL31156397 0.98 MAOA (0.59) FABP4FABP5MAOAMAOBACHE
SCHEMBL2700651 0.98 MAOA (0.59) FABP4FABP5MAOAMAOBACHE
SCHEMBL1472359 0.98 MAOA (0.59) FABP4FABP5MAOAMAOBACHE
SCHEMBL30576402 0.98 MAOA (0.59) FABP4FABP5MAOAMAOBACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104447504-B A kind of carbazolyl-containing group M-phthalic acid fluorescence chemical sensor, prepare and apply 北京工业大学 2016-10-26 CN claimed
CN-104447504-A Carbazole group-containing m-phthalic acid fluorescence chemosensor and preparation and application thereof UNIV BEIJING TECHNOLOGY 2015-03-25 CN claimed
WO-2024085603-A1 COMPOSITION FOR PREVENTING OR TREATING C-MYC-ASSOCIATED DISEASES THROUGH INHIBITION OF EXPRESSION OF UBIQUITIN-SPECIFIC PROTEASE 47 (USP47), AND USE THEREOF 이화여자대학교 산학협력단 2024-04-25 WO disclosed
WO-2023120963-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING LUNG CANCER COMPRISING CARBAZOLE DERIVATIVE COMPOUND AS ACTIVE INGREDIENT 한국과학기술연구원 2023-06-29 WO disclosed
US-20220388966-A1 NOVEL COMPOUND HAVING ANTIBACTERIAL FUNCTION AGAINST SUPERBACTERIA AND SELECTIVE DETECTION FUNCTION OF HYPOCHLOROUS ACID, AND COMPOSITION AND SENSOR COMPRISING THE SAME PUKYONG NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION (KR) 2022-12-08 US disclosed
CN-108794382-B Multifunctional aggregation-induced emission enhancement compound and preparation method and application thereof 华南师范大学 2021-08-03 CN disclosed
CN-108559484-B A kind of alkyl bromide is for carbazole derivates room temperature phosphorimetry material and its preparation and application 太原理工大学 2019-08-02 CN disclosed
CN-106045977-B A kind of bipolarity blue phosphorescent material of main part based on carbazole and 1,2,4- triazole 太原理工大学 2019-03-15 CN disclosed
WO-2018225086-A1 METHOD AND DEVICE FOR RAPID DETECTION OF HEARNPV INDIAN INSTITUTE OF SCIENCE (IN) 2018-12-13 WO disclosed
WO-2018225086-A1 METHOD AND DEVICE FOR RAPID DETECTION OF HEARNPV INDIAN INSTITUTE OF SCIENCE (IN) 2018-12-13 WO disclosed
US-9663464-B2 Carbazole derivatives acting on 5-HT7 receptor KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2017-05-30 US disclosed
CN-1780897-A Novel electroluminescent materials COVION ORGANIC SEMICONDUCTORS (DE) 2006-05-31 CN disclosed
EP-1641894-A1 NOVEL MATERIALS FOR ELECTROLUMINESCENCE Covion Organic Semiconductors GmbH (DE) 2006-04-05 EP disclosed
CN-1631890-A Tetraphenyl porphyrin derivative and its application in organic electroluminescent device UNIV JILIN (CN) 2005-06-29 CN disclosed
WO-2004113468-A1 NOVEL MATERIALS FOR ELECTROLUMINESCENCE COVION ORGANIC SEMICONDUCTORS GMBH (DE) 2004-12-29 WO disclosed
CN-1050604-C Compound with antipsychotic effect MEIJI SEIKA KABUSHIKA KAISHA (JP) 2000-03-22 CN disclosed
US-5599815-A SIDE EFFECT REDUCTION MEIJI SEIKA KABUSHIKI KAISHA (JP) 1997-02-04 US disclosed
CN-1103534-A Compound with antipsychotic effect MEIJI SEIKA CO (JP) 1995-06-07 CN disclosed
EP-0635506-A1 COMPOUND WITH ANTIPSYCHOTIC EFFECT MEIJI SEIKA KABUSHIKI KAISHA (JP) 1995-01-25 EP disclosed
US-3981848-A PENDANT TRICYANOVINYLCARBAZOLE GROUPS XEROX CORPORATION (US) 1976-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220388966-A1 NOVEL COMPOUND HAVING ANTIBACTERIAL FUNCTION AGAINST SUPERBACTERIA AND SELECTIVE DETECTION FUNCTION OF HYPOCHLOROUS ACID, AND COMPOSITION AND SENSOR COMPRISING THE SAME HDHD5, MPO, HAO2 FABP4 2650/4885FABP5 570/4885MAOA 1373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.